iAtoday

In the news for several years, the Government of Canada introduced Bill C-64 last February, defining the principles for the first phase of a national, universal drug plan.

While the goal of improving the health, wellbeing and quality of life of all Canadians is highly laudable, what is the real scope of this bill and this new plan?

Frédéric Leblanc, Strategic Leader, Drug Programs at iA Financial Group, will address this question in a Canadian Pension and Benefits Institute (CPBI) webinar on October 22.

He will be joined by Paul Kennedy, Chief Health Actuary at Mercer Marsh Benefits.

Interested in this topic? Join us on October 22, from 1:00 to 2:00 pm (ET).

¹ Act now! The number of free places is limited.